BioStock News

@biostock-news.bsky.social

2 months ago

New data points to improved muscle function for patients with Charcot-Marie-Tooth disease. NMD Pharma reports consistent functional gains in its Phase IIa study of ignaseclant. #NMDPharma #CMT